Mirae Asset Global Investments Co., Ltd. Personalis, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$2.89 - $5.32 $18,423 - $33,915	-6,375 Reduced 5.25%	115,035 $341,000
Q2 2022 Aug 15, 2022	BUY	$3.27 - $8.76 $397,010 - $1.06 Million	121,410 New	121,410 $419,000
Q2 2022 Jul 26, 2022	SELL	$3.27 - $8.76 $381,559 - $1.02 Million	-116,685 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$7.56 - $14.3 $123,795 - $234,162	-16,375 Reduced 12.31%	116,685 $955,000
Q4 2021 Feb 08, 2022	SELL	$12.24 - $21.25 $716,884 - $1.24 Million	-58,569 Reduced 30.56%	133,060 $1.9 Million
Q3 2021 Nov 15, 2021	SELL	$16.69 - $26.05 $613,774 - $957,988	-36,775 Reduced 16.1%	191,629 $3.69 Million
Q2 2021 Aug 11, 2021	BUY	$18.15 - $27.75 $1.41 Million - $2.16 Million	77,779 Added 51.64%	228,404 $5.78 Million
Q1 2021 May 13, 2021	BUY	$20.71 - $51.02 $877,172 - $2.16 Million	42,355 Added 39.12%	150,625 $3.71 Million
Q4 2020 Feb 10, 2021	BUY	$21.84 - $44.0 $1.15 Million - $2.31 Million	52,474 Added 94.05%	108,270 $3.96 Million
Q3 2020 Nov 12, 2020	BUY	$13.63 - $24.12 $760,499 - $1.35 Million	55,796 New	55,796 $1.21 Million

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $265M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.